Kilbourn MR - Search Results

1

[18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor.

Welch MJ, Raichle ME, Kilbourn MR, Mintun MA. Welch MJ, et al. Among authors: kilbourn mr. Ann Neurol. 1984;15 Suppl:S77-8. doi: 10.1002/ana.410150714. Ann Neurol. 1984. PMID: 6611130 No abstract available.

2

Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.

Welch MJ, Kilbourn MR, Mathias CJ, Mintun MA, Raichle ME. Welch MJ, et al. Among authors: kilbourn mr. Life Sci. 1983 Oct 24;33(17):1687-93. doi: 10.1016/0024-3205(83)90725-7. Life Sci. 1983. PMID: 6633162

3

Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis.

Perlmutter JS, Kilbourn MR, Welch MJ, Raichle ME. Perlmutter JS, et al. Among authors: kilbourn mr. J Neurosci. 1989 Jul;9(7):2344-52. doi: 10.1523/JNEUROSCI.09-07-02344.1989. J Neurosci. 1989. PMID: 2787394 Free PMC article.

4

N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.

Welch MJ, Katzenellenbogen JA, Mathias CJ, Brodack JW, Carlson KE, Chi DY, Dence CS, Kilbourn MR, Perlmutter JS, Raichle ME, et al. Welch MJ, et al. Among authors: kilbourn mr. Int J Rad Appl Instrum B. 1988;15(1):83-97. doi: 10.1016/0883-2897(88)90164-x. Int J Rad Appl Instrum B. 1988. PMID: 3258305

5

Strategies for in vivo measurement of receptor binding using positron emission tomography.

Perlmutter JS, Larson KB, Raichle ME, Markham J, Mintun MA, Kilbourn MR, Welch MJ. Perlmutter JS, et al. Among authors: kilbourn mr. J Cereb Blood Flow Metab. 1986 Apr;6(2):154-69. doi: 10.1038/jcbfm.1986.29. J Cereb Blood Flow Metab. 1986. PMID: 3485640

6

MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans.

Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ. Perlmutter JS, et al. Among authors: kilbourn mr. Neurology. 1987 Oct;37(10):1575-9. doi: 10.1212/wnl.37.10.1575. Neurology. 1987. PMID: 3498914

7

Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol.

Kilbourn MR, Welch MJ, Dence CS, Tewson TJ, Saji H, Maeda M. Kilbourn MR, et al. Int J Appl Radiat Isot. 1984 Jul;35(7):591-8. doi: 10.1016/0020-708x(84)90101-7. Int J Appl Radiat Isot. 1984. PMID: 6469389

8

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. Mintun MA, et al. Among authors: kilbourn mr. Ann Neurol. 1984 Mar;15(3):217-27. doi: 10.1002/ana.410150302. Ann Neurol. 1984. PMID: 6609679

9

Fluorine-18 labeled receptor based radiopharmaceuticals.

Kilbourn MR, Welch MJ. Kilbourn MR, et al. Int J Rad Appl Instrum A. 1986;37(8):677-83. doi: 10.1016/0883-2889(86)90261-3. Int J Rad Appl Instrum A. 1986. PMID: 2876971 No abstract available.

10

Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors.

Welch MJ, Chi DY, Mathias CJ, Kilbourn MR, Brodack JW, Katzenellenbogen JA. Welch MJ, et al. Among authors: kilbourn mr. Int J Rad Appl Instrum B. 1986;13(5):523-6. doi: 10.1016/0883-2897(86)90132-7. Int J Rad Appl Instrum B. 1986. PMID: 3818316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters